Home
/
LEMAITRE VASCULAR INC
/
Financials
/
Quarterly
LEMAITRE VASCULAR INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LEMAITRE VASCULAR INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$54.82M
Nov 8, 2024
Q2
2024
Jun 30, 2024
$55.85M
Aug 8, 2024
Q1
2024
Mar 31, 2024
$53.48M
May 10, 2024
Q3
2024
Sep 30, 2023
$47.41M
Nov 8, 2024
Q3
2023
Jun 30, 2023
$47.41M
Nov 7, 2023
Q2
2024
Jun 30, 2023
$50.12M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$47.08M
May 10, 2024
Q3
2022
Sep 30, 2022
$39.03M
Nov 8, 2022
Q2
2023
Jun 30, 2022
$42.11M
Aug 8, 2023
Q3
2023
Jun 30, 2022
$39.03M
Nov 7, 2023
Q1
2023
Mar 31, 2022
$39.56M
May 9, 2023
Q3
2022
Sep 30, 2021
$38.37M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$40.67M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$35.88M
May 10, 2022
Q3
2021
Sep 30, 2020
$36.42M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$24.85M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$30.55M
May 10, 2021
Q3
2020
Sep 30, 2019
$29.10M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$29.48M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$28.48M
May 8, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$25.99M
May 4, 2018
Q3
2017
Sep 30, 2017
$24.82M
Nov 3, 2017
Q2
2017
Jun 30, 2017
$25.75M
Aug 3, 2017
Q1
2018
Mar 31, 2017
$24.14M
May 4, 2018
Q3
2017
Sep 30, 2016
$23.22M
Nov 3, 2017
Q2
2017
Jun 30, 2016
$22.39M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$20.26M
May 4, 2017
Q3
2016
Sep 30, 2015
$19.03M
Nov 4, 2016
Q2
2016
Jun 30, 2015
$19.90M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$18.95M
May 6, 2016
Q3
2015
Sep 30, 2014
$17.50M
Nov 6, 2015
Q2
2015
Jun 30, 2014
$18.16M
Aug 6, 2015
Q1
2015
Mar 31, 2014
$16.75M
May 7, 2015
Q3
2014
Sep 30, 2013
$15.30M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$15.95M
Aug 7, 2014
Q1
2014
Mar 31, 2013
$15.38M
May 8, 2014
Q3
2013
Sep 30, 2012
$13.65M
Nov 7, 2013
Q2
2013
Jun 30, 2012
$14.36M
Aug 9, 2013
Q1
2013
Mar 31, 2012
$13.93M
May 8, 2013
Q3
2012
Sep 30, 2011
$14.56M
Nov 9, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$17.36M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$13.78M
Aug 6, 2025
Q3
2025
Jun 30, 2025
$13.78M
Nov 7, 2025
Q1
2025
Mar 31, 2025
$11.01M
May 8, 2025
Q3
2025
Mar 31, 2025
$11.01M
Nov 7, 2025
Q2
2025
Mar 31, 2025
$11.01M
Aug 6, 2025
Q3
2025
Sep 30, 2024
$11.14M
Nov 7, 2025
Q3
2025
Jun 30, 2024
$11.83M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$11.83M
Aug 6, 2025
Q2
2025
Mar 31, 2024
$9.89M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$9.89M
May 8, 2025
Q3
2025
Mar 31, 2024
$9.89M
Nov 7, 2025
Q3
2024
Sep 30, 2023
$7.50M
Nov 8, 2024
Q3
2024
Jun 30, 2023
$8.10M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$8.10M
Aug 8, 2024
Q3
2024
Mar 31, 2023
$6.04M
Nov 8, 2024
Q1
2024
Mar 31, 2023
$6.04M
May 10, 2024
Q2
2024
Mar 31, 2023
$6.04M
Aug 8, 2024
Q3
2023
Sep 30, 2022
$5.46M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$3.52M
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.31M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$16.14M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$12.63M
May 8, 2025
Q3
2025
Sep 30, 2024
$13.15M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$14.38M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$11.87M
May 8, 2025
Q3
2024
Sep 30, 2023
$9.18M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$9.45M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$7.87M
May 10, 2024
Q3
2023
Sep 30, 2022
$6.15M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$5.78M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$7.93M
May 9, 2023
Q3
2022
Sep 30, 2021
$9.07M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$11.11M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$7.95M
May 10, 2022
Q3
2021
Sep 30, 2020
$10.02M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$4.87M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$4.35M
May 10, 2021
Q3
2020
Sep 30, 2019
$5.91M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$5.92M
Aug 6, 2020